CoChat

Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo‐controlled,double‐blind, multicentre study

Riccardi, G., Giacco, R., Parillo, M., Turco, S., Rivellese, A. A., Ventura, M. R., Contadini, S., Marra, G., Monteduro, M., Santeusanio, F., Brunetti, P., Librenti, M. C., Pontiroli, A. E., Vedani, P., Pozza, G., Bergamini, L., Bianchi, C. · 1999 · Diabetic Medicine
Cited by 50

The DOI matches its Crossref record.

Abstract

Summary: Aims The aim of the study was to evaluate the efficacy and safety of acarbose in patients with Type 1 diabetes mellitus (DM). Methods A multicentre double‐blind, randomized, placebo‐controlled study was performed. After a 6‐week run‐in, 121 patients were randomized to acarbose or placebo and to high‐ or low‐fibre diet for 24 weeks. Acarbose dose was 50 mg t.d.s. for the first 2 weeks and 100 mg t.d.s. for the subsequent weeks. Results At the end of 24 weeks of treatment the intention to treat analysis showed that acarbose compared with placebo decreased 2 h postprandial plasma glucose levels (12.23 ± 0.83 vs. 14.93 ± 0.87 mmol/l;F = 6.1, P < 0.02) (least square means ± sem). No significant effect of acarbose was recorded on HbA 1c or on the number of hypoglycaemic episodes. The effect of acarbose on blood glucose control was not influenced by the amount of carbohydrate and/or fibre intake. The incidence of adverse events were 75% and 39% in acarbose and placebo groups, respectively; they were mild and confined to the gastrointestinal tract. Conclusions The use of acarbose in combination with insulin reduces postprandial plasma glucose levels in Type 1 diabetic patients who are not satisfactorily controlled with insulin alone but without significant effect on HbA 1c. Diabet. Med. 16, 228–232 (1999)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.1999.00047.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 50

Metadata

Authors
Riccardi, G., Giacco, R., Parillo, M., Turco, S., Rivellese, A. A., Ventura, M. R., Contadini, S., Marra, G., Monteduro, M., Santeusanio, F., Brunetti, P., Librenti, M. C., Pontiroli, A. E., Vedani, P., Pozza, G., Bergamini, L., & Bianchi, C.
Venue
Diabetic Medicine
Publisher
Wiley
Published
1999-03
Volume
16
Issue
3
Pages
228-232
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2071716514
Cited by
50
References
0
FWCI
0.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo‐controlled,double‐blind, multicentre study. https://app.cochat.ai/papers/10.1046/j.1464-5491.1999.00047.x
The paper
Riccardi, G., Giacco, R., Parillo, M., Turco, S., Rivellese, A. A., Ventura, M. R., Contadini, S., Marra, G., Monteduro, M., Santeusanio, F., Brunetti, P., Librenti, M. C., Pontiroli, A. E., Vedani, P., Pozza, G., Bergamini, L., & Bianchi, C. (1999). Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo‐controlled,double‐blind, multicentre study. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.1999.00047.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.